Literature DB >> 24614435

Multiple myeloma and diagnostic imaging.

Carol Reisenbuckler.   

Abstract

Multiple myeloma is the most common primary bone cancer among U.S. adults aged 70 years and older, and the incidence of the disease is increasing. Despite significant advances in treatment since the 1960s, multiple myeloma remains a challenging disease to diagnose and treat. Several medical diagnostic imaging examinations play important roles. This article reviews the biological basis of multiple myeloma, clinical features and diagnosis of the disease, and imaging and treatment protocols. The article also discusses unusual presentations of multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614435

Source DB:  PubMed          Journal:  Radiol Technol        ISSN: 0033-8397


  6 in total

1.  BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.

Authors:  Ellen Weisberg; Basudev Chowdhury; Chengcheng Meng; Abigail E Case; Wei Ni; Swati Garg; Martin Sattler; Abdel Kareem Azab; Jennifer Sun; Barbara Muz; Dana Sanchez; Anthia Toure; Richard M Stone; Ilene Galinsky; Eric Winer; Scott Gleim; Sofia Gkountela; Alexia Kedves; Edmund Harrington; Tinya Abrams; Thomas Zoller; Andrea Vaupel; Paul Manley; Michael Faller; BoYee Chung; Xin Chen; Philipp Busenhart; Christine Stephan; Keith Calkins; Debora Bonenfant; Claudio R Thoma; William Forrester; James D Griffin
Journal:  Blood Cancer J       Date:  2022-07-19       Impact factor: 9.812

2.  Problem Management Plus in the treatment of mental disorders in patients with multiple myeloma.

Authors:  Hong Zhang; Dongxiu Zhang; Hailong Lin; Leting Huang
Journal:  Support Care Cancer       Date:  2020-01-22       Impact factor: 3.603

3.  Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.

Authors:  Xi Yun Zhang; Deepa Rajagopalan; Tae-Hoon Chung; Lissa Hooi; Tan Boon Toh; Johann Shane Tian; Masturah Bte Mohd Abdul Rashid; Noor Rashidha Bte Meera Sahib; Mengjie Gu; Jhin Jieh Lim; Wilson Wang; Wee Joo Chng; Sudhakar Jha; Edward Kai-Hua Chow
Journal:  Exp Hematol Oncol       Date:  2020-05-22

4.  PHD finger protein 19 expression in multiple myeloma: Association with clinical features, induction therapy outcome, disease progression, and survival.

Authors:  Yaqiong Li; Jichang Gong; Lingli Zhang
Journal:  J Clin Lab Anal       Date:  2021-08-13       Impact factor: 2.352

5.  HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA/Slug axis.

Authors:  Lisha Zheng; Ang Zhang; Jishan Liu; Min Liu; Yikun Zhang
Journal:  Int J Mol Med       Date:  2021-11-05       Impact factor: 4.101

6.  Integrated Analysis of a Risk Score System Predicting Prognosis and a ceRNA Network for Differentially Expressed lncRNAs in Multiple Myeloma.

Authors:  Sijie Zhou; Jiuyuan Fang; Yan Sun; Huixiang Li
Journal:  Front Genet       Date:  2020-08-27       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.